Please use this identifier to cite or link to this item:
Title: GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons
Author: De La Torre, A.V.
Junyent, F.
Folch, J.
Pelegri, C.
Vilaplana, J.
Auladell, C.
Beas-Zárate, Carlos
Pallas, M.
Verdaguer, E.
Camins, A.
Issue Date: 2012
Abstract: In the present study, we evaluated the effects of roscovitine (Rosco) and flavopiridol (Flavo), both of which are classified as cyclin-dependent kinase (CDK) inhibitors, on apoptosis induced by the inhibition of PI3K/AKT pathway in cerebellar granule neurons (CGNs). Our results demonstrate that both CDK inhibitors prevented apoptosis induced by LY294002 (LY), as also occurs with SB415286 (SB4), a selective GSK3β inhibitor. Our findings also indicate that these CDK inhibitors inhibit GSK3β, representing a potential pharmacological mechanism involved in their neuroprotective properties. Thus, the increased activity of GSK3β induced by LY294002 and detected by dephosphorylation at Ser9 was prevented by both compounds. Likewise, GSK3β activity was measured by a radioactivity assay, revealing that CDK inhibitors and SB415286 prevented the increase in GSK3β activity induced by PI3K inhibition. In addition, we analysed c-Jun, which is also a mediator of PI3K inhibition-induced apoptosis. However, neither of the CDK inhibitors nor SB415286 prevented the increase in c-Jun phosphorylation induced by PI3K inhibition. Therefore, our data identify GSK3β as a crucial mediator of CGN apoptosis induced by PI3K inhibition and indicate that the antiapoptotic effects of CDKs are mediated by the inhibition of this pharmacological target. © 2011 Elsevier Ltd. All rights reserved.
Appears in Collections:Producción científica UdeG (prueba)

Files in This Item:
There are no files associated with this item.

Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.